N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects

N Engl J Med. 2020 Nov 26;383(22):2182-2184. doi: 10.1056/NEJMc2031173. Epub 2020 Nov 15.

Authors

Affiliations

¹ Imperial College London, London, United Kingdom research@cardiologists.london.
² Imperial College Healthcare NHS Trust, London, United Kingdom.
³ Sheffield University Management School, Sheffield, United Kingdom.
⁴ Imperial College London, London, United Kingdom.
⁵ King's College London, London, United Kingdom.

PMID: 33196154
DOI: 10.1056/NEJMc2031173

No abstract available

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Atorvastatin / adverse effects*
Confidence Intervals
Double-Blind Method
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Placebos / adverse effects*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Placebos
Atorvastatin

Grants and funding